论文部分内容阅读
目的通过引入葛根注射液治疗急性心肌梗死,观察治疗过程中血浆BNP水平的变化,为临床治疗提供重要依据。方法选取2014年1月~2016年1月在怀安县医院就诊的急性心肌梗死患者102例,所有患者根据入院编号进行分组,其中单号为研究组,双号为对照组,各51例,对照组给予常规治疗,研究组在此基础上给予葛根注射液治疗。结果研究组和对照组的患者血浆BNP指标均得到了有效的改善,但是研究组患者降低BNP效果更好。结论对急性心肌梗死患者引入葛根素注射液治疗,疗效确切,能够有利于患者心脏功能的好转,改善患者的预后,值得积极推荐。
Objective To introduce the Puerarin injection in the treatment of acute myocardial infarction and to observe the change of plasma BNP level during the course of treatment, so as to provide an important basis for clinical treatment. Methods From January 2014 to January 2016, 102 patients with acute myocardial infarction in Huai’an County Hospital were enrolled. All patients were divided into two groups according to admission number, including single study group and double-control group, with 51 cases in each group Group given conventional treatment, the study group on the basis of Puerarin injection treatment. Results Both BNP and BNP levels in study group and control group were significantly improved, but BNP was better in study group. Conclusion The introduction of puerarin injection in patients with acute myocardial infarction, curative effect is exact, can be beneficial to the improvement of cardiac function and improve the prognosis of patients, it is worth recommending.